Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cann Group ( (AU:CAN) ) just unveiled an announcement.
Cann Group Limited has executed a forbearance and settlement deed with National Australia Bank, releasing the company from its existing loan obligations in exchange for a $15.30 million payment. This move is part of a broader debt restructuring strategy that includes securing new loans and raising capital through institutional placements and a share purchase plan. The restructuring is expected to strengthen Cann Group’s financial position and support its ongoing operations, potentially enhancing its market position and providing stability for stakeholders.
More about Cann Group
Cann Group Limited operates in the pharmaceutical industry, focusing on the cultivation and production of medicinal cannabis products. The company is based in Australia and aims to leverage its expertise in cannabis cultivation to serve both domestic and international markets.
YTD Price Performance: -71.79%
Average Trading Volume: 3,364,740
Technical Sentiment Signal: Sell
Current Market Cap: A$9.06M
For an in-depth examination of CAN stock, go to TipRanks’ Overview page.